Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants

NCT03169881 is registered in ClinicalTrials.gov with NICHD Neonatal Research Network as lead sponsor.

NCT NCT03169881
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03169881 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants
Lead sponsor
NICHD Neonatal Research Network
Phase
Phase 3
Overall status
Completed
Start date
September 20, 2017
Completion date
May 12, 2025
Enrollment
650 (actual)
Sites
16

Conditions

As the registry lists them; a condition with its own page is linked.

neonatal, neurocognitive, neurodevelopmental impairment, neuroprotective